This Article Full Text (PDF) All Versions of this Article: 1076029607303771v1 15/3/297    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Stief, T. W. Articles by Renz, H. PubMed PubMed Citation Articles by Stief, T. W. Articles by Renz, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE CHLORAMINE T Medline Plus Health Information Heart Attack Social Bookmarking                         What's this?

Monitoring of Functional Plasminogen in the Blood of Patients on Fibrinolytics

Department of Laboratory Medicine, Hospital of Philipps-University, Marburg, Germany, thstief{at}med.uni-marburg.de

Anette Richter, MD

Department of Cardiology, Hospital of Philipps-University, Marburg, Germany

Bernhard Maisch, MD

Department of Laboratory Medicine, Hospital of Philipps-University, Marburg, Germany

Harald Renz, MD

Department of Laboratory Medicine, Hospital of Philipps-University, Marburg, Germany

There are no reliable data on functional plasminogen in the blood of patients receiving fibrinolytic treatment. Here, artifactual in vitro changes of functional plasminogen were prevented by arginine stabilization blood samples of myocardial infarction patients: 12 received 36.4 mg reteplase in bolus, and 1 patient received 100 mg tissue plasminogen activator in continuous infusion. Arginine (1.5 M, 1.3 mL, pH 8.7) was used to stabilize 2.6 mL ethylenediaminetetraacetic acid-blood. The arginine-stabilized plasma was analyzed with a functional oxidative assay for plasminogen. Functional plasminogen decreased within 2 minutes of reteplase treatment by about 40% and by about 80% after 60 minutes. Lowest plasminogen concentrations were found in plasmas with highest plasmin activities. Chloramine oxidation of purified Glu-plasminogen increased its activation by urokinase up to 3-fold. Arginine stabilization allows reliable determinations of functional plasminogen in the blood of patients receiving fibrinolytics, enabling the rapid diagnosis of prothrombotic plasminogen consumption. The present findings support the profibrinolytic action of chloramines.

Key Words: plasminogen • plasmin • plasminogen activator • thrombolysis • hemostasis

This version was published on June 1, 2009

Clinical and Applied Thrombosis/Hemostasis, Vol. 15, No. 3, 297-308 (2009)
DOI: 10.1177/1076029607303771


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?